GW-501516 (Cardarine) Research Solution in Canada
This listing supplies GW-501516 (Cardarine) as a labelled liquid research solution for laboratory identification, analytical comparison, and controlled research workflows. It is not a dietary supplement, medication, or product for human or veterinary use.
Product specifications
| Compound | GW-501516 (Cardarine) |
|---|---|
| Classification | PPAR-delta agonist; it is not a SARM |
| Listed concentration | 20 mg/mL |
| Volume | 30 mL |
| Total listed compound | 600 mg |
| Format | Labelled liquid research solution |
| Documentation | See Testing & COA Documentation |
Compare bottle and bundle contents
This listing is one 30 mL bottle of GW-501516 (Cardarine) 20 mg/mL. To compare buying this bottle separately with a bundle that includes it, review the exact additional bottles below.
- MK-2866 (Ostarine) + GW-501516 (Cardarine) Research Stack: 2 separate 30 mL bottles (MK-2866 (Ostarine) 25 mg/mL; GW-501516 (Cardarine) 20 mg/mL).
- RAD-140 + GW-501516 (Cardarine) Research Stack: 2 separate 30 mL bottles (RAD-140 (Testolone) 10 mg/mL; GW-501516 (Cardarine) 20 mg/mL).
Compare by supplied contents and format. Catalogue bundles do not establish combined effects or a recommendation to use compounds together.
Compound identity and classification
GW-501516 (Cardarine) is classified as a PPAR-delta agonist; it is not a SARM. Correct classification matters when comparing research catalogues: related compounds can appear beside SARMs without sharing the same primary target or mechanism.
GW-501516 has been investigated as a peroxisome proliferator-activated receptor delta (PPAR-delta) agonist, including small, short-duration human studies of lipid and metabolic markers. Those exploratory studies were limited in size and duration and do not establish an approved therapy, general safety, or suitability for personal use.
Published findings should be read as study-specific observations, not as proof of efficacy, safety, or a recommendation for use outside an authorized research setting.
Understanding the listed concentration
The listed concentration of 20 mg/mL describes the product format. In a 30 mL bottle, this corresponds to 600 mg of listed compound in total. Concentration information supports inventory control and analytical planning; it is not dosage, cycle, or administration guidance.
Request a Certificate of Analysis
To request a copy of the applicable Certificate of Analysis (COA), email [email protected]. Include the product name and, if available, your order number.
The applicable COA identifies the incoming material batch tested. It is separate from the finished bottle’s labelled concentration. See Testing & COA Documentation for an explanation of the report fields.
Research-use boundaries and handling
This product is sold strictly for laboratory and research purposes. It is not intended for human consumption, therapeutic use, bodybuilding use, athletic performance use, veterinary use, or the diagnosis, treatment, cure, or prevention of disease.
Keep the container sealed and follow the storage information on its label or accompanying documentation. Record the product name, concentration, receipt date, and applicable documentation in laboratory inventory records. Contact support for product-specific documentation or handling questions.
Frequently asked questions
What does this bottle contain?
It contains one labelled 30 mL liquid research solution of GW-501516 (Cardarine) at a listed concentration of 20 mg/mL, representing 600 mg of listed compound in total.
Is GW-501516 a SARM?
GW-501516 (Cardarine) is a PPAR-delta agonist; it is not a SARM. This classification is provided for catalogue accuracy and should not be interpreted as a safety or efficacy claim.
How do I request a COA copy?
To request a copy of the applicable Certificate of Analysis (COA), email [email protected]. Include the product name and, if available, your order number.
Does this page provide dosage or cycle guidance?
No. Concentration describes the supplied research format only. Canada SARMs does not provide dosage, cycle, administration, bodybuilding, or medical guidance.
Where can I compare research documentation?
Review the Research Library, the Complete SARMs Guide, and the FAQ.
Reviews
There are no reviews yet.